Mimori K - Search Results

1

GTF2IRD1 on chromosome 7 is a novel oncogene regulating the tumor-suppressor gene TGFβR2 in colorectal cancer.

Nambara S, Masuda T, Kobayashi Y, Sato K, Tobo T, Koike K, Noda M, Ogawa Y, Kuroda Y, Ito S, Eguchi H, Sugimachi K, Mimori K. Nambara S, et al. Among authors: mimori k. Cancer Sci. 2020 Feb;111(2):343-355. doi: 10.1111/cas.14248. Epub 2019 Dec 27. Cancer Sci. 2020. PMID: 31758608 Free PMC article.

2

Localization of thymidine phosphorylase expression in colorectal carcinoma tissues by in situ RT-PCR assay.

Mimori K, Matsuyama A, Yoshinaga K, Yamashita K, Masuda T, Inoue H, Ueo H, Mori M. Mimori K, et al. Oncology. 2002;62(4):327-32. doi: 10.1159/000065064. Oncology. 2002. PMID: 12138240

3

MAL gene expression in esophageal cancer suppresses motility, invasion and tumorigenicity and enhances apoptosis through the Fas pathway.

Mimori K, Shiraishi T, Mashino K, Sonoda H, Yamashita K, Yoshinaga K, Masuda T, Utsunomiya T, Alonso MA, Inoue H, Mori M. Mimori K, et al. Oncogene. 2003 May 29;22(22):3463-71. doi: 10.1038/sj.onc.1206378. Oncogene. 2003. PMID: 12776198

4

N-cadherin is regulated by activin A and associated with tumor aggressiveness in esophageal carcinoma.

Yoshinaga K, Inoue H, Utsunomiya T, Sonoda H, Masuda T, Mimori K, Tanaka Y, Mori M. Yoshinaga K, et al. Among authors: mimori k. Clin Cancer Res. 2004 Sep 1;10(17):5702-7. doi: 10.1158/1078-0432.CCR-03-0262. Clin Cancer Res. 2004. PMID: 15355896

5

Coexpression of matrix metalloproteinase-7 (MMP-7) and epidermal growth factor (EGF) receptor in colorectal cancer: an EGF receptor tyrosine kinase inhibitor is effective against MMP-7-expressing cancer cells.

Mimori K, Yamashita K, Ohta M, Yoshinaga K, Ishikawa K, Ishii H, Utsunomiya T, Barnard GF, Inoue H, Mori M. Mimori K, et al. Clin Cancer Res. 2004 Dec 15;10(24):8243-9. doi: 10.1158/1078-0432.CCR-04-0849. Clin Cancer Res. 2004. PMID: 15623600

6

Detection of occult cancer cells in peripheral blood and bone marrow by quantitative RT-PCR assay for cytokeratin-7 in breast cancer patients.

Masuda TA, Kataoka A, Ohno S, Murakami S, Mimori K, Utsunomiya T, Inoue H, Tsutsui S, Kinoshita J, Masuda N, Moriyama N, Mori M. Masuda TA, et al. Among authors: mimori k. Int J Oncol. 2005 Mar;26(3):721-30. Int J Oncol. 2005. PMID: 15703829

7

Somatic mutations of epidermal growth factor receptor in colorectal carcinoma.

Nagahara H, Mimori K, Ohta M, Utsunomiya T, Inoue H, Barnard GF, Ohira M, Hirakawa K, Mori M. Nagahara H, et al. Among authors: mimori k. Clin Cancer Res. 2005 Feb 15;11(4):1368-71. doi: 10.1158/1078-0432.CCR-04-1894. Clin Cancer Res. 2005. PMID: 15746034

8

Clinicopathologic and prognostic values of apolipoprotein D alterations in hepatocellular carcinoma.

Utsunomiya T, Ogawa K, Yoshinaga K, Ohta M, Yamashita K, Mimori K, Inoue H, Ezaki T, Yoshikawa Y, Mori M. Utsunomiya T, et al. Among authors: mimori k. Int J Cancer. 2005 Aug 10;116(1):105-9. doi: 10.1002/ijc.20986. Int J Cancer. 2005. PMID: 15756681

9

Clinical significance of human kallikrein gene 6 messenger RNA expression in colorectal cancer.

Ogawa K, Utsunomiya T, Mimori K, Tanaka F, Inoue H, Nagahara H, Murayama S, Mori M. Ogawa K, et al. Among authors: mimori k. Clin Cancer Res. 2005 Apr 15;11(8):2889-93. doi: 10.1158/1078-0432.CCR-04-2281. Clin Cancer Res. 2005. PMID: 15837738

10

Clinicopathologic and biological significance of kallikrein 6 overexpression in human gastric cancer.

Nagahara H, Mimori K, Utsunomiya T, Barnard GF, Ohira M, Hirakawa K, Mori M. Nagahara H, et al. Among authors: mimori k. Clin Cancer Res. 2005 Oct 1;11(19 Pt 1):6800-6. doi: 10.1158/1078-0432.CCR-05-0943. Clin Cancer Res. 2005. PMID: 16203767

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

514 results

Search Page

Filters